Prof. Dr. ERKİNGÜL BİRDAY

1. Articles published in international peer-reviewed journals:

1. M.Pehlivan, M.Kürtüncü, E.Tüzün, E.Shugaiv, M.Mutlu, M.Eraksoy, G.Akman-Demir The comparison of socio-economic conditions and personal hygiene habits of neuro-Behçet's disease and multiple sclerosis patients. International Journal of Hygiene and Environmental Health, 214, 335-337 pp., June-2011, DOI: 10.1016/j.ijheh.2011.04.001

2. E.Shugaiv, E.Tüzün, M.Mutlu, A.Kiyat-Atamer, M.Kurtuncu, G.Akman-Demir Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behçet's disease with parenchymal involvement: presentation of four cases. Clinical and Experimental Rheumatology, 2011, Sept (4 Suppl 67):, 64-67 pp.

3. M.Kürtüncü, E.Tüzün, R.Türkoğlu, B.Petek-Balcı, S.İçöz, M.Pehlivan, O.Birişik, C.Ulusoy, E.Shugaiv, G.Akman-Demir, M.Eraksoy Effect of short-term interferon-b treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23. Cytokine. 59, 400-402 pp., August-2012, DOI: 10.1016/j.cyto.2012.05.004

4. E.Shugaiv, I.M.Leite, E.Sehitoglu, M.Woodhall, F.Çavus, P.Waters, S.Içöz, O.Birisik, E.Ugurel, C.Ulusoy, M.Kürtüncü, B.Vural, A.Vincent, G.Akman-Demir, E.Tüzün Progressive Encephalomyelitis with Rigidity and Myoclonus: a Syndrome with Diverse Clinical Features and Antibody Responses: European Neurology 2013;69(5):257-62. doi: 10.1159/000342237. Epub 2013 Feb 20.

5. A.Kıyat Atamer, E.Ekizoğlu, E.Tuzun, M.Kurtuncu, E.Shugaiv, G.Akman-Demir, M.Eraksoy, Long-term MRI findings in neuromyelitis optica: seropositive vs. seronegative patients: Eur J Neurol. 2013 May;20(5):781-7. doi: 10.1111/ene.12058.

6. E.Shugaiv, A.Kiyat-Atamer, E.Tuzun, F.Deymeer, P.Oflazer, Y.Parman, G.Akman Demir Coexistence of Guillain-Barre syndrome and Behcet's disease. Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):88-9. Epub 2013 Feb 25

7. A.Arıkanoglu, E.Shugaiv, E.Tüzün, M.Eraksoy Impact of Cigarette Smoking on Conversion from Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis. Int J Neurosci. 2013 Jul;123(7):476-9. doi: 10.3109/00207454.2013.764498.

8. G.Saruhan-Direskeneli, S.P.Yenitur, M.Mutlu, E.Shugaiv, N.Yeşilot, M.Kürtüncü, G.Akman-Demir. Intrathecal oligoclonal IgG bands are infrequently found in neuro-Behçet's disease. Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):25-7.

9. V.Öztürk, M.Ertaş, B.Baykan, H.Sirin, A.Özge; Mig-Etol Study Group (E.Shugaiv). Efficacy and safety of 400 and 800 mg etodolac vs. 1,000 mg paracetamol in acute treatment of migraine: a randomized, double-blind, crossover, multicenter, phase III clinical trial. Pain Pract. 2013 Mar;13(3):191-7. doi: 10.1111/j.1533-2500.2012.00572.x.

10. E.Shugaiv, A.Kıyat-Atamer, E.Tüzün, M.Kürtüncü, I.Baral-Kulaksızoğlu, G.Akman Demir. Kleptomania in Patients with Neuro-Behcet's Disease. Medical Principles and Practice DOI:10.1159/000351798 Med Princ Pract. 2013;22:550-4. Epub 2013 Jul 30.

11. B.Vural, E.Şehitoğlu, F.Çavuş, N.Yalçınkaya, H.Haytural, M.Küçükerden, C.Ulusoy, E.Ugurel, S.Turan, L.Bulut, R.Türkoğlu, E.Shugaiv, M.Kürtüncü, Ş.Atakan, A.O.Güre, A.Gül, M.Eraksoy, G.Akman-Demir, E.Tüzün. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease J Neuroimmunol. 2013 Oct 15;263(1-2):139-44. doi: 10.1016/j.jneuroim.2013.08.007. Epub 2013 Aug 24.

12. M.Woodhall, A.Çoban, P.Waters, E.Ekizoğlu, M.Kürtüncü, E.Shugaiv, R.Türkoğlu, G.Akman-Demir, M.Eraksoy, A.Vincent, E.Tüzün. Glycine Receptor and Myelin Oligodendrocyte Glycoprotein Antibodies in Turkish Patients with Neuromyelitis Optica Journal of the Neurological Sciences, doi; J Neurol Sci. 2013 Dec 15;335(1-2):221-3. doi: 10.1016/j.jns.2013.08.034. Epub 2013 Sep 3.

13. E.Shugaiv, E.Tüzün, M.Kürtüncü, A.Kıyat-Atamer, A.Coban, G.Akman-Demir, I.Tugal-Tutkun, M.Eraksoy. Uveitis as a prognostic factor in multiple sclerosis. Mult Scler. 2014 Jun 16. pii: 1352458514539782

14. B.Petek-Balcı, A.Coban, E.Shugaiv, R.Türkoğlu, C.Ulusoy, S.Içöz, M.Pehlivan, E.Tüzün, G.Akman-Demir, M.Kürtüncü, M.Eraksoy. Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis. Int J Neurosci. 2014 Jul 17

15. Cİ.Küçükali, H.Haytural, G.Benbir, A.Coban, C.Ulusoy, M.Giriş, M.Kürtüncü, E.Shugaiv, D.Karadeniz, E.Tüzün. Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients. J Neurol Sci. 2014 Nov 15;346(1-2):353-5. doi: 10.1016/j.jns.2014.08.041.

16. E.Tüzün, J.Tzartos, E.Ekizoğlu, C.Stergiou, P.Zisimopoulou, A.Coban, E.Shugaiv, R.Türkoğlu, M.Kürtüncü, B.Baykan, S.Tzartos. Aquaporin-1 antibody in neuromyelitis optica patients. Eur Neurol. 2014;72(5-6):271-2. doi: 10.1159/000364904

17. G.Akman-Demir, M.Mutlu, A.Kıyat Atamer, E.Shugaiv, M.Kürtüncü, I.Tugal-Tutkun, E.Tüzün, M.Eraksoy, S.Bahar. Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria. Clin Exp Rheumatol. 2015:33(Suppl 94):80-4.

A18. Çoban A, Shugaiv E, Tüzün E. Syndrome of Headache Accompanied with Transient Neurologic Deficits and Cerebrospinal Fluid Lymphocytosis. Noro Psikiyatr Ars. 2013 Aug;50(Suppl 1):S52-S55. doi: 10.4274/npa.y7228. Epub 2013 Aug 1.

A19. Atmaca MM, Altiokka Uzun G, Shugaiv E, Kürtüncü M, Eraksoy M. Association of Demyelinating and Inflammatory Bowel Diseases: A Case Series and Overview of the Literature. Noro Psikiyatr Ars. 2015 Sep;52(3):315-318. doi: 10.5152/npa.2015.8725. Epub 2015 Jul 7.

2. Papers presented at international scientific meetings and published in proceedings:

1. Z.Matur, A.Çoban, G.Babacan, E.Shugaiv, H.Hanağası, Y.Parman. Botulinum Toxin Injections For The Facial Region. ENS 19-23 June 2010, Berlin, Germany

2. S.Bıçakçı, A.Özge, G.Seydaoğlu, Y.Sarıca, Turkish Headache Database Study Group (E.Shugaiv) Comorbid conditions with migraine. 2nd European Headache and Migraine Trust. 28-31 Oct 2010. Nice, France

3. D.U.Uludüz, A.Özge, A.Siva, G.Ö. Temel, A.Kanık, Turkish Headache Database Study Group (E.Shugaiv) Overlapping features of migraine and tension-type headache, new insight to continuum hypothesis. 2nd European Headache and Migraine Trust. 28-31 Oct 2010. Nice, France

4. Y.Parman, Z.Matur, E.Shugaiv, E.Ilgaz-Aydınlar, E.Battaloğlu, P.Oflazer, F.Deymeer Clinico-Pathological and genetic study of familial transthyretin-type amyloid polyneuropathy. Meeting of the Peripheral Nerve Society. June 25-29, 2011 Potomac, Maryland

5. Z.Matur, E.Shugaiv, F.Deymeer, P.Oflazer, E.Battaloğlu, Y.Parman. Autonomic dysfunction in CMT. The 4th International CMT Consortium June 29-July 1, 2011. Potomac, Maryland

6. G.Akman-Demir, M.Mutlu, A.Kiyat-Atamer, E.Shugaiv, M.Kurtuncu, İ.Tugal-Tutkun, E.Tüzün, S.Bahar. White Matter Lesions in Behçet's Disease: Neuro-Behçet's Disease or Multiple Sclerosis? AAN, Apr 2012. USA

7. E.Erdag, E.Tuzun, G.Akman-Demir, E.Shugaiv, E.Sehitoglu, F.Cavus, E.Ugurel, C.Ulusoy, S.Turan, M.Kurtuncu, B.Vural: Progressive encephalomyelitis with rigidity and myoclonus: a syndrome with diverse clinical features and antibody responses: 11th International Congress of Neuroimmunology. 4-8 Nov 2012. BOSTON, USA

8. E.Shugaiv, M.Kurtuncu, M.Mutlu, G.Akman-Demir, İlknur Tugal-Tutkun, E.Tüzün, M.Eraksoy: Uveitis in patients with multiple sclerosis. 11th International Congress of Neuroimmunology. 4-8 Nov 2012. BOSTON, USA

9. E.Shugaiv, E.Tuzun, G.Akman-Demir, I.Tugal Tutkun, M.Eraksoy: A Case with treatment-resistant multiple sclerosis-associated panuveitis: 9-year follow-up. EUNOS 11th Meeting April 10-13, Oxford, UK

10. M.Kürtüncü, E.Tüzün, B.Petek-Balcı, E.Birday, A.Çoban, R.Türkoğlu, S.İçöz, M.Pehlivan, C.Ulusoy, G.Akman-Demir, M.Eraksoy. Reduction of IL 9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients. 29th ECTRIMS 2-5 October 2013, Copenhagen, Denmark

11. A.Çoban, J.Tzartos, C.Stergiou, G.Akman Demir, P.Zisimopoulou, E.Shugaiv, S.İçöz, E.Tüzün, M.Kürtüncü, M.Eraksoy, S.Tzartos. Autoantibodies to aquaporin-1 in Turkish neuromyelitis optica patients with and without aquaporin-4 antibodies. 29th ECTRIMS 2-5 October 2013, Copenhagen, Denmark

12. E.Shugaiv, E.Tüzün, A.Çoban, M.Pehlivan, M.Kurtuncu, I.Tugal-Tutkun, G.Akman-Demir, M.Eraksoy. Uveitis as a prognostic factor in multiple sclerosis patients. 29th ECTRIMS 2-5 October 2013, Copenhagen, Denmark

13. E.Shugaiv, M.Kurtuncu, M.Mutlu, G.Akman-Demir, İlknur Tugal-Tutkun, E.Tüzün, M.Eraksoy: Uveitis in patients with multiple sclerosis. ECTRIMS. 10-13 Oct 2012, LYON, FRANCE

14. G.Akman-Demir, M.Mutlu, A.Kiyat-Atamer, E.Shugaiv, M.Kurtuncu, İ.Tugal-Tutkun, E.Tüzün, S.Bahar. White Matter Lesions in Behçet's Disease: Neuro-Behçet's Disease or Multiple Sclerosis? ECTRIMS. 10-13 Oct 2012, LYON, FRANCE

15. E.Uğurel, E.Şehitoğlu, M.Kurtuncu, E.Shugaiv, C.Ulusoy, M.Küçükerden, A.Çoban, E.Tuzun, B.Vural. Gene expression profiles of neuro-Behçet's disease during active and inactive stages. ENS 2014, Istanbul, TURKEY

16. E.Shugaiv, A.çoban, M.Kurtuncu, E.Tuzun, G.Akman-Demir, M.Eraksoy. Coexistence of neuromyelitis optica and seizures: A case report ENS 2014, Istanbul, TURKEY

17. B.Nurova, M.Kurtuncu, A.Çoban, E.Birday, M.Eraksoy. Computer assisted cognitive rehabilitation in patients with multiple sclerosis and parenchymal neuro-Behçet's disease ENS 2014, Istanbul, TURKEY

3. Articles published in national peer-reviewed journals:

1. B.Güveli, C.Gürses, S.Yılmazer, E.Shugaiv, N.Bebek, B.Baykan, A.Gökyiğit. A Case of Marinesco-Sjögren Syndrome with Epilepsy. Düşünen Adam; 2009, 22 (1-4): 27-31

2. E.Uğurel, A.Karabulut, A.Gül, A.O.Güre, E.Shugaiv, E.Tüzün, U.Özbek, B.Vural. Investigation of Swap 70 Antibody in Behçet's Disease Patients, DETAE Year:2, Volume:2, Issue 4; 22-29.

3. E.Shugaiv, G.İbrahimova, Z.Karaaslan, A.C.Bozkaya, M.Kürtüncü, M.Eraksoy. Cerebrotendinous Xanthomatosis with Cerebellar Vacuolization. Turkish Journal of Neurology: March 2013: Volume:19, Issue 1; 39.

4. E.Shugaiv, M.M.Atmaca, E.Ekizoğlu, M.Kürtüncü, M.Eraksoy. Trauma and Multiple Sclerosis. Kırıkkale University Faculty of Medicine Journal. 2013; 16 (3): 33-36

5. E.Shugaiv, A.Aydoseli, E.Kocasoy Orhan, İ.Güngör, A.N.İzgi, M.Eraksoy. A case of spinal AVF mimicking demyelinating disease. Clinical Medicine Family Practice Journal May-June 2014: Volume:6 Issue: 3

6. E.Shugaiv, E.Aksoy Güzeller, S.Alim. Optic Disc Drusen in the Differential Diagnosis of Optic Neuritis. Turkish Journal of Neurology. Ref No: TJN-56514

7. E.Shugaiv, S.Yumerhodzha, İ.Güngör, EN.Vanlı, M.Kürtüncü, M.B.Baslo, M.Eraksoy. Coexistence of Multiple Sclerosis and Chronic Polyneuropathy: A Case Report. Clinical Medicine Family Practice Journal. May-June 2014: Volume:6 Issue: 3

8. Ö.A.Düz, N.Y.Helvacı, E.Birday, G.Akan, A.Bilici. Brain Metastasis in a Patient with Malignant Melanoma: Melanotic Pattern DOI:10.4274/tnd.22309 Turk J Neurol 2017;23:79-80

9. B.Altunrende, E.Birday, M.Kasap, G.Akman The Use of Fingolimod in Relapsing Remitting Multiple Sclerosis Turk J Neurol. In Press: TJN-62144, 2017

4. Papers presented at national scientific meetings and published in proceedings:

1. S.Yılmazer, E.Shugaiv, C.Gürses, N.Bebek, B.Baykan, A.Gökyiğit. A case presentation with a preliminary diagnosis of Marinesco-Sjögren syndrome: 5th National Epilepsy Congress, 7-10 June. Bursa 2006-ORAL

2. E.Shugaiv, H.Hanağası, H.Gürvit, J.Yazıcı, M.Emre. L-DOPA responsive dystonia: Two case reports. 41st National Neurology Congress, Istanbul 2005

3. E.Shugaiv, F.İlğen, N.Bebek, O.Çoban, R.Tuncay, S.Bahar. A case diagnosed with HELLP syndrome presenting with hyperperfusion syndrome involving bilateral extensive basal ganglia and upper brainstem involvement. 41st National Neurology Congress, Istanbul 2005

4. A.Çoban, E.Shugaiv, N.Bebek, O.Çoban, R.Tunçay, S.Bahar. A case of pontine hematoma associated with preeclampsia in a 34-week pregnant woman: 41st National Neurology Congress, Istanbul 2005

5. E.Shugaiv, F.İ.Genç, N.Bebek, C.Gürses, B.Baykan, A.Gökyiğit. Evaluation of patients presenting to the Emergency Neurology service with epileptic seizures. 5th National Epilepsy Congress. Bursa 2006.

6. E.Shugaiv, B.Şenergin, P.Oflazer, F.Deymeer, M.A.Akalın, E.Battaloğlu, Y.Parman Clinicopathological and Genetic Study of Autosomal Dominant and Recessive Axonal Charcot-Marie-Tooth Disease. 44th National Neurology Congress-Antalya 2008-ORAL

7. M.Mutlu, U.Çıkrıkçılı, Ş.Yıldız, A.Hemzeli, E.Shugaiv, M.Eraksoy. Parry-Romberg syndrome as a rare and interesting presentation in the differential diagnosis of multiple sclerosis: case report and literature review. 47th National Neurology Congress. Antalya 2011

8. A.Arıkanoğlu, E.Shugaiv, E.Tüzün, M.Eraksoy. The Effect of Smoking on the Conversion Process from Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis. 48th National Neurology Congress-Antalya 16-22 November 2012

9. M.M.Atmaca, E.Shugaiv, M.Eraksoy. Crohn's Disease with White Matter Involvement: Case Report. 48th National Neurology Congress-Antalya 16-22 November 2012

10. E.Shugaiv, E.Pabuşçu, B.Myftyıu, S.Yumerhodzha, M.Eraksoy. Observational Results Regarding Fingolimod Use in the Multiple Sclerosis Unit of the Department of Neurology, Istanbul Faculty of Medicine: 48th National Neurology Congress-Antalya 2012-ORAL

11. E.Shugaiv, E.Tüzün, M.Kürtüncü, I.Baral Kulaksızoğlu, G.Akman Demir, Kleptomania in Neuro-Behçet's Patients 48th National Neurology Congress-Antalya 2012-ORAL

12. A.Çoban, B.Petek-Balcı, E.Shugaiv, R.Türkoğlu, C.Ulusoy, S.İçöz, M.Pehlivan, E.Tüzün, G.Akman-Demir, M.Kürtüncü, M.Eraksoy. Does the change in early serum cytokine levels in multiple sclerosis have a predictive role on the long-term efficacy of interferon-beta 1A therapy? 49th National Neurology Congress 15-21 November 2013, Antalya-ORAL

13. E.Shugaiv, E.Tüzün, A.Çoban, M.Pehlivan, M.Kürtüncü, I.Tugal-Tutkun, G.Akman-Demir, M.Eraksoy. The effect of uveitis on the course of multiple sclerosis 49th National Neurology Congress 15-21 November 2013, Antalya-ORAL

14. E.Shugaiv, M.Mutlu, Ö.Gelişin, S.Sencer, M.Eraksoy. Diagnostic and therapeutic approaches in tumefactive, large, inflammatory demyelinating lesions: case report and literature review. 47th National Neurology Congress. Antalya 2011

15. M.Mutlu, E.Shugaiv, A.Hemzeli, M.Eraksoy. Multiple sclerosis in the course of Wegener's Granulomatosis. 47th National Neurology Congress. Antalya 2011

16. E.Shugaiv, B.Baykan. Late-Onset Migraine with Aura. 48th National Neurology Congress-Antalya 16-22 November 2012

17. E.Shugaiv, E.Tüzün, M.Kürtüncü, G.Akman-Demir, İ.Tugal-Tutkun, M.Eraksoy. Multiple sclerosis and uveitis. 6th Neuroimmunology School: 28 February-3 March, Antalya

18. E.Shugaiv, E.Tüzün, M.Kürtüncü, G.Akman Demir, İ.Tugal Tutkun, M.Eraksoy. Multiple sclerosis and panuveitis: a case report with 9-year follow-up. 6th Neuroimmunology School: 28 February-3 March, Antalya

19. E.Shugaiv, M.M.Atmaca, E.Ekizoğlu, M.Kürtüncü, M.Eraksoy The relationship between trauma and multiple sclerosis. 6th Neuroimmunology School: 28 February-3 March, Antalya

20. E.Shugaiv, G.İbrahimova, İ.Güngör, S.Yumerjodzha, M.Kürtüncü, M.B.Baslo, M.Eraksoy. Coexistence of multiple sclerosis and chronic polyneuropathy: Case report. 6th Neuroimmunology School: 28 February-3 March, Antalya

21. A.Arıkanoğlu, E.Shugaiv, A.Çoban, E.Tüzün, M.Eraksoy. The predictive value of MRI and disability in the conversion process from clinically isolated syndrome to clinically definite multiple sclerosis. 6th Neuroimmunology School: 28 February-3 March, Antalya

22. M.Karbay, M.Pehlivan, E.Birday, A.Çoban, M.Kürtüncü, M.Eraksoy. Determination of normal values of vibration sense duration. 49th National Neurology Congress 15-21 November 2013, Antalya

23. B.Nurova Gökçeimam, E.Birday, A.Çoban, T.Gündüz, M.Kürtüncü, M.Eraksoy. The effect of computer-assisted cognitive rehabilitation in Multiple Sclerosis. 49th National Neurology Congress 15-21 November 2013, Antalya

24. A.Çoban, J.Tzartos, C.Stergiou, G.Akman Demir, P.Zisimopoulou, E.Shugaiv, S.İçöz, E.Tüzün, M.Kürtüncü, M.Eraksoy, S.Tzartos. Aquaporin-1 antibody: A newly identified antibody in Neuromyelitis Optica patients with and without Aquaporin-4 antibodies. 49th National Neurology Congress 15-21 November 2013, Antalya

25. A.Çakar, Z.Karaaslan, M.Karbay, E.Birday, A.Çoban, M.Pehlivan, M.Kürtüncü, M.Eraksoy. A case of Natalizumab-associated Progressive Multifocal Leukoencephalopathy: 49th National Neurology Congress 15-21 November 2013, Antalya

26. A.Çakar, Z.Karaaslan, E.Birday, A.Çoban, M.Kürtüncü. A case of glioblastoma presenting with carcinomatous meningitis clinical features. 49th National Neurology Congress 15-21 November 2013, Antalya

27. E.Birday-Shugaiv, P.Dağcıoğlu. Clinical and demographic characteristics of patients followed with a diagnosis of multiple sclerosis at the Neurology Clinic of Tokat State Hospital. 50th National Neurology Congress 21-27 November 2014, Antalya

28. E.Birday-Shugaiv, B.Bayraktar, M.Terzi. A case of spinal meningioma mimicking demyelinating disease. 50th National Neurology Congress 21-27 November 2014, Antalya

29. A.Çoban, Cİ.Küçükali, H.Haytural, G.Benbir, A.Coban, C.Ulusoy, M.Giriş, M.Kürtüncü, E.Shugaiv, D.Karadeniz, E.Tüzün. Serum orexin-A levels in Neuromyelitis Optica and Autoimmune Encephalitis. 50th National Neurology Congress 21-27 November 2014, Antalya

30. Ş.Yıldız-Çelik, E.Tüzün, G.Akman-Demir, A.Çoban, S.İçöz, E.Birday, B.Bilgiç, H.Hanağası, H.Gürvit, H.Durmuş, P.Oflazer, Y.Parman, F.Deymeer, M.Kürtüncü, M.Eraksoy. Prognosis of Patients with Anti-Neuronal Antibodies. Oral presentation: 50th National Neurology Congress 21-27 November 2014, Antalya

31. M.Kürtüncü, Ş.Yıldız-Çelik, A.Çoban, E.Birday, M.Pehlivan, G.Akman-Demir, M.Eraksoy. Comparison of Retention Times of Multiple Sclerosis Patients on Disease-Modifying Therapies. Oral presentation: 50th National Neurology Congress 21-27 November 2014, Antalya

32. Ş.Yıldız-Çelik, A.Çoban, E.Birday, M.Kürtüncü, M.Eraksoy. Multiple Sclerosis with Normal Magnetic Resonance Imaging: Myth or Reality? 50th National Neurology Congress 21-27 November 2014, Antalya

33. Ö.A.Düz, N.Y.Helvacı, E.Birday, B.Polat, G.Akan, F.F.Özer, L.Hanoğlu Leptomeningeal Carcinomatosis Presenting with Increased Intracranial Pressure Syndrome in Different Cancer Types. 52nd National Neurology Congress 25 November-1 December 2016, Antalya

34. Ö.A.Düz, Ş.Kılıç, U.Yaka, D.Taşkın, S.Ş.Bilgin, E.Birday, F.F.Özer. Neurosarcoidosis Cases with Different Presentations and a Review of the Literature. 52nd National Neurology Congress 25 November-1 December 2016, Antalya

35. E.Birday, U.Yaka, S.Ş.Bilgin, B.Polat, Ş.Kılıç, M.Can, F.F.Özer. Coexistence of Familial Mediterranean Fever (FMF) and Longitudinally Extensive Transverse Myelitis (LETM): Case Report. 52nd National Neurology Congress 25 November-1 December 2016, Antalya

36. Ş.Kılıç, N.H.Yılmaz, E.Birday, E.E.Altay, E.Khanmammadov, F.F.Özer. A Rare Autoimmune Encephalitis: LGI-1 Antibody Positivity. 52nd National Neurology Congress 25 November-1 December 2016, Antalya

37. Ö.A.Düz, Ş.Kılıç, U.Yaka, S.Ş.Bilgin, G.Akan, E.Birday. Area Postrema Syndrome: Case Report 52nd National Neurology Congress 25 November-1 December 2016, Antalya

Roles in Projects:

1. Evaluation of the Efficacy of Etodolac in the Treatment of Migraine Attacks: A Crossover, Randomized, Double-Blind, Comparative, Phase IV Study - Sub-investigator

2. FTY 720/D2301-Phase III (Novartis): A 24-month, double-blind, randomized, multicenter, placebo-controlled, parallel-group study comparing efficacy and safety of FTY720 1.25 mg and 0.5 mg administered orally once daily versus placebo in patients with relapsing-remitting multiple sclerosis. - Sub-investigator

3. FTY 720/2301E1-(Novartis): An extension of the 24-month, double-blind, randomized, multicenter, placebo-controlled, parallel-group study comparing efficacy and safety of FTY720 1.25 mg and 0.5 mg administered orally once daily versus placebo in patients with relapsing-remitting multiple sclerosis. - Sub-investigator

4. FTY 720/D2399-Phase III (Novartis): A single arm, open-label, multicenter study evaluating the long-term safety, tolerability and efficacy of 0.5 mg Fingolimod (FTY720) administered orally once daily in patients with multiple sclerosis. - Sub-investigator

5. BAF 312-A2201 Phase II (Novartis): A phase II, double-blind, randomized, multicenter, adaptive dose-ranging, placebo-controlled, parallel-group study evaluating safety, tolerability and efficacy on MRI lesion parameters and determining the dose-response curve of BAF312 given orally once daily in patients with relapsing-remitting multiple sclerosis. - Sub-investigator

6. CBAF 312-A2201 E1: (Novartis): An extension study to the CBAF312A2201 study to evaluate long-term safety, tolerability and efficacy of BAF312 given orally once daily in patients with relapsing-remitting multiple sclerosis. - Sub-investigator

7. EFC 6260-Phase III (Sanofi-Aventis): TOPIC "An international, multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy and safety of a two-year treatment with teriflunomide once daily at doses of 7mg and 14mg versus placebo in patients who have experienced a first clinical episode suggestive of multiple sclerosis." - Sub-investigator.

8. EFC 10531-Phase III (Sanofi-Aventis): TOWER "A multicenter, double-blind, parallel-group, placebo-controlled study to investigate the efficacy and safety of teriflunomide in patients with relapsing multiple sclerosis." - Sub-investigator.